Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
雅培公司股票上漲，因公司宣佈與利潔時本奇共同贏得早產兒配方訴訟的首次審判，並被證實沒有隱瞞腸道疾病風險的指控。
Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
雅培公司股票上漲，因公司宣佈與利潔時本奇共同贏得早產兒配方訴訟的首次審判，並被證實沒有隱瞞腸道疾病風險的指控。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間